相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center A Retrospective Cohort Analysis
Benjamin D. Powers et al.
ANNALS OF SURGERY (2021)
Detection of Chemotherapy-resistant Pancreatic Cancer Using a Glycan Biomarker, sTRA
ChongFeng Gao et al.
CLINICAL CANCER RESEARCH (2021)
A MET Targeting Antibody-Drug Conjugate Overcomes Gemcitabine Resistance in Pancreatic Cancer
Alex Cazes et al.
CLINICAL CANCER RESEARCH (2021)
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma
R. Nicolle et al.
ANNALS OF ONCOLOGY (2021)
Trials and tribulations of pancreatic cancer immunotherapy
Daniel R. Principe et al.
CANCER LETTERS (2021)
Laparoscopic Versus Open Pancreaticoduodenectomy A Systematic Review and Meta-analysis of Randomized Controlled Trials
Felix Nickel et al.
ANNALS OF SURGERY (2020)
Completion of adjuvant therapy in patients with resected pancreatic cancer
Danielle K. DePeralta et al.
HPB (2020)
Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer
Christopher Nevala-Plagemann et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation
Eileen M. O'Reilly et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis
Mao Ye et al.
HPB (2020)
Updated risk factors to inform early pancreatic cancer screening and identify high risk patients
Daniel R. Principe et al.
CANCER LETTERS (2020)
Small Molecule KRAS Inhibitors: The Future for Targeted Pancreatic Cancer Therapy?
Josef Gillson et al.
CANCERS (2020)
Frequency and prognostic value of mutations associated with the homologous recombination DNA repair pathway in a large pan cancer cohort
Daniel R. Principe et al.
SCIENTIFIC REPORTS (2020)
Disparities in pancreatic ductal adenocarcinoma - the significance of Hispanic ethnicity, by subgroup analysis, and treatment facility on clinical outcomes
Andrea N. Riner et al.
CANCER RESEARCH (2020)
Long-term gemcitabine treatment reshapes the pancreatic tumor microenvironment and sensitizes murine carcinoma to combination immunotherapy
Daniel R. Principe et al.
CANCER RESEARCH (2020)
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Resection of pancreatic cancer in Europe and USA: an international large-scale study highlighting large variations
Lei Huang et al.
GUT (2019)
Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
Georgios Gemenetzis et al.
ANNALS OF SURGERY (2019)
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery
Yoshihiro Miyasaka et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Randomized trial of oral versus enteral feeding for patients with postoperative pancreatic fistula after pancreatoduodenectomy
J. -M. Wu et al.
BRITISH JOURNAL OF SURGERY (2019)
Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer
Vivek K. Kashyap et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
Thorvardur R. Halfdanarson et al.
ONCOLOGIST (2019)
Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial
Teresa Macarulla et al.
JOURNAL OF GERIATRIC ONCOLOGY (2019)
Cytosolic 5′-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites
Melanie S. Patzak et al.
EBIOMEDICINE (2019)
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P. Janssen et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved Survival
Ariella M. Altman et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the US National Cancer Database
M. J. Passeri et al.
CURRENT ONCOLOGY (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A meta-analysis of randomized controlled trials comparing laparoscopic vs open pancreaticoduodenectomy
Fabio Ausania et al.
HPB (2019)
Systematic review of functional outcome and quality of life after total pancreatectomy
L. Scholten et al.
BRITISH JOURNAL OF SURGERY (2019)
Outcome and long-term quality of life after total pancreatectomy (PANORAMA): a nationwide cohort study
Lianne Scholten et al.
SURGERY (2019)
A prospective single-center protocol for using near-infrared fluorescence imaging with indocyanine green during staging laparoscopy to detect small metastasis from pancreatic cancer
Sachiyo Shirakawa et al.
BMC SURGERY (2019)
Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD) A Multicenter Patient-blinded Randomized Controlled Trial
Thijs de Rooij et al.
ANNALS OF SURGERY (2019)
TGFβ Blockade Augments PD-1 Inhibition to Promote T-Cell-Mediated Regression of Pancreatic Cancer
Daniel R. Principe et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Optimizing the outcomes of pancreatic cancer surgery
Oliver Strobel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer
Yanfei Jia et al.
ONCOGENE (2019)
Randomized phase II/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02/JSAP05)
Fuyuhiko Motoi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2019)
Cutting-edge strategies for borderline resectable pancreatic cancer
Rajesh S. Shinde et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2019)
Effect of ribonucleotide reductase M1 expression on overall survival in patients with pancreatic cancer receiving gemcitabine chemotherapy: A literature-based meta-analysis
Q. L. Han et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2018)
Minimally invasive surgical approaches offer earlier time to adjuvant chemotherapy but not improved survival in resected pancreatic cancer
Katelin A. Mirkin et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2018)
KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
Andrew M. Waters et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
Health Disparities Impact Expected Treatment of Pancreatic Ductal Adenocarcinoma Nationally
Waseem Lutfi et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Meta-analysis of an artery-first approach versus standard pancreatoduodenectomy on perioperative outcomes and survival
N. Ironside et al.
BRITISH JOURNAL OF SURGERY (2018)
Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor
Matthew R. Janes et al.
CELL (2018)
Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations
Zishuo I. Hu et al.
CLINICAL CANCER RESEARCH (2018)
The Additional Value of Laparoscopic Ultrasound to Staging Laparoscopy in Patients with Suspected Pancreatic Head Cancer
Gijs A. Looijen et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2018)
Impact of age on survival of patients with pancreatic cancer after surgery: Analysis of SEER data
Xiaogang Li et al.
PANCREATOLOGY (2018)
Preoperative biliary drainage in resectable pancreatic cancer: a systematic review and network meta-analysis
Peter J. Lee et al.
HPB (2018)
Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways
Yang Li et al.
CELL DEATH & DISEASE (2018)
Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer
Ryan Nipp et al.
CANCER MEDICINE (2018)
Cancer-associated cachexia
Vickie E. Baracos et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2018)
Comparison of Perioperative Outcomes Between Laparoscopic and Open Approach for Pancreatoduodenectomy The PADULAP Randomized Controlled Trial
Ignasi Poves et al.
ANNALS OF SURGERY (2018)
Incidence and risk factors for abdominal occult metastatic disease in patients with pancreatic adenocarcinoma
Georgios Gemenetzis et al.
JOURNAL OF SURGICAL ONCOLOGY (2018)
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer
T. Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Staging laparoscopy with ultrasound and near-infrared fluorescence imaging to detect occult metastases of pancreatic and periampullary cancer
H. J. M. Handgraaf et al.
PLOS ONE (2018)
Clinical benefit of entrectinib for patients with metastatic pancreatic cancer who harbor NTRK and ROS1 fusions.
Michael J. Pishvaian et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
Lingfeng He et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma
Vincent P. Groot et al.
ANNALS OF SURGERY (2018)
Taxol®: The First Microtubule Stabilizing Agent
Chia-Ping Huang Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
A phase Ib/II pilot trial with nab-paclitaxel plus gemcitabine plus cisplatin in patients (pts) with stage IV pancreatic cancer.
Gayle S. Jameson et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
5-FU resistant EMT-like pancreatic cancer cells are hypersensitive to photochemical internalization of the novel endoglin-targeting immunotoxin CD105-saporin
Kaja Lund et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)
Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs
June S. Peng et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2017)
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John P. Neoptolemos et al.
LANCET (2017)
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Sushrut Kamerkar et al.
NATURE (2017)
Minimally invasive versus open distal pancreatectomy for ductal adenocarcinoma (DIPLOMA): A European propensity score matched study
Jony van Hilst et al.
PANCREATOLOGY (2017)
Hippo pathway mediates resistance to cytotoxic drugs
Taranjit S. Gujral et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
Leore T. Geller et al.
SCIENCE (2017)
Preoperative biliary stenting versus operation first in jaundiced patients due to malignant lesions in the pancreatic head: A meta-analysis of current literature
Florian Scheufele et al.
SURGERY (2017)
A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer
Daniel Delitto et al.
SURGERY (2017)
Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
Alexander Drilon et al.
CANCER DISCOVERY (2017)
Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis
Yu Zong et al.
ONCOTARGET (2017)
Macropinocytosis of Nab-paclitaxel Drives Macrophage Activation in Pancreatic Cancer
Jane Cullis et al.
CANCER IMMUNOLOGY RESEARCH (2017)
Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary
Davendra P. S. Sohal et al.
JOURNAL OF ONCOLOGY PRACTICE (2017)
Tobacco and alcohol as risk factors for pancreatic cancer
Murray Korc et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2017)
Predictive value of hENT1 immunohistochemistry for gemcitabine-treated pancreatic cancer is antibody dependent.
Dimas Yusuf et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
A semi-automated assessment of sarcopenia using psoas area and density predicts outcomes after pancreaticoduodenectomy for pancreatic malignancy
Jukes P. Namm et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
Randomized clinical trial of laparoscopic versus open pancreatoduodenectomy for periampullary tumours
C. Palanivelu et al.
BRITISH JOURNAL OF SURGERY (2017)
Time to Initiation of Adjuvant Chemotherapy in Pancreas Cancer: A Multi-Institutional Experience
Brent T. Xia et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction
Xin Jin et al.
CANCER RESEARCH (2017)
Going the Extra Mile Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers
Michael E. Lidsky et al.
ANNALS OF SURGERY (2017)
Modified Frailty Index Predicts Morbidity and Mortality After Pancreaticoduodenectomy
Harveshp Mogal et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Pancreatic cancer: Stroma and its current and emerging targeted therapies
Janaiah Kota et al.
CANCER LETTERS (2017)
Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma
Daniel P. Nussbaum et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma
F. Giovinazzo et al.
BRITISH JOURNAL OF SURGERY (2016)
Micro RNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR
Baotong Zhang et al.
ONCOTARGET (2016)
Early Enteral Versus Total Parenteral Nutrition in Patients Undergoing Pancreaticoduodenectomy: A Randomized Multicenter Controlled Trial (Nutri-DPC)
Julie Perinel et al.
ANNALS OF SURGERY (2016)
Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer
Srinivasa P. Pothula et al.
BRITISH JOURNAL OF CANCER (2016)
Time to the Initiation of Adjuvant Chemotherapy Does Not Impact Survival in Patients With Resected Pancreatic Cancer
Katelin A. Mirkin et al.
CANCER (2016)
TGFβ Signaling in the Pancreatic Tumor Microenvironment Promotes Fibrosis and Immune Evasion to Facilitate Tumorigenesis
Daniel R. Principe et al.
CANCER RESEARCH (2016)
Loss of P53 Function Activates JAK2-STAT3 Signaling to Promote Pancreatic Tumor Growth, Stroma Modification, and Gemcitabine Resistance in Mice and Is Associated With Patient Survival
Sonja M. Woermann et al.
GASTROENTEROLOGY (2016)
Learning Curve for Laparoscopic Pancreaticoduodenectomy: a CUSUM Analysis
Mingjun Wang et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2016)
Pulmonary metastasectomy for suspected pancreaticobiliary cancer
Lary A. Robinson et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2016)
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
Mustafa Suker et al.
LANCET ONCOLOGY (2016)
Distal Pancreatectomy With En Bloc Celiac Axis Resection for Locally Advanced Pancreatic Cancer A Systematic Review and Meta-Analysis
Haibing Gong et al.
MEDICINE (2016)
A wait-and-see strategy with subsequent self-expanding metal stent on demand is superior to prophylactic bypass surgery for unresectable periampullary cancer
Caroline Williamsson et al.
HPB (2016)
Projections of cancer incidence and cancer-related deaths inGermany by 2020 and 2030
Anne S. Quante et al.
CANCER MEDICINE (2016)
Delineating the Role of βIV- Tubulins in Pancreatic Cancer: βIVb- Tubulin Inhibition Sensitizes Pancreatic Cancer Cells to Vinca Alkaloids
G. Sharbeen et al.
NEOPLASIA (2016)
Pancreatic cancer
Jorg Kleeff et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer
Song-Fa Zhang et al.
AUTOPHAGY (2015)
Non-adherent culture induces paclitaxel resistance in H460 lung cancer cells via ERK-mediated up-regulation of βIVa-tubulin
Korakot Atjanasuppat et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma
David Fogelman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
miR-16 targets Bcl-2 in paclitaxel-resistant lung cancer cells and overexpression of miR-16 along with miR-17 causes unprecedented sensitivity by simultaneously modulating autophagy and apoptosis
Abhisek Chatterjee et al.
CELLULAR SIGNALLING (2015)
Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer
Hannah A. Blair et al.
DRUGS (2015)
Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumourchemoresistance
Camille Duluc et al.
EMBO MOLECULAR MEDICINE (2015)
Inhibition of thymidylate synthase by 2′,2′-difluoro-2′-deoxycytidine (Gemcitabine) and its metabolite 2′,2′-difluoro-2′-deoxyuridine
Richard J. Honeywell et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer
Daniel V. T. Catenacci et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Extended Versus Standard Lymphadenectomy for Pancreatic Head Cancer: Meta-Analysis of Randomized Controlled Trials
Bobby V. M. Dasari et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base
Susan M. Sharpe et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)
Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer
Ken-ichi Fujita et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Intracellular annexin A2 regulates NF-kappa B signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer
H. Jung et al.
CELL DEATH & DISEASE (2015)
Paracrine SDF-1α signaling mediates the effects of PSCs on GEM chemoresistance through an IL-6 autocrine loop in pancreatic cancer cells
Hui Zhang et al.
ONCOTARGET (2015)
Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells
Jia Ma et al.
ONCOTARGET (2015)
Assessment of Quality Outcomes for Robotic Pancreaticoduodenectomy Identification of the Learning Curve
Brian A. Boone et al.
JAMA SURGERY (2015)
Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma
Joseph M. Herman et al.
CANCER (2015)
Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with collateral hypersensitivity to histone deacetylase inhibitors
Betty K. Samulitis et al.
CANCER BIOLOGY & THERAPY (2015)
βIII-Tubulin: A novel mediator of chemoresistance and metastases in pancreatic cancer
Joshua A. McCarroll et al.
ONCOTARGET (2015)
Roles of the Bcl-2/Bax Ratio, Caspase-8 and 9 in Resistance of Breast Cancer Cells to Paclitaxel
Simin Sharifi et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
Andrew D. Rhim et al.
CANCER CELL (2014)
Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer
Masaki Mori et al.
CELL (2014)
Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
Susann Weissmueller et al.
CELL (2014)
Nab-paclitaxel: A flattering facelift
A. Viudez et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2014)
Gemcitabine Resistance is Associated with Epithelial-Mesenchymal Transition and Induction of HIF-1 alpha in Pancreatic Cancer Cells
Rui Wang et al.
CURRENT CANCER DRUG TARGETS (2014)
Benefit from synchronous portal-superior mesenteric vein resection during pancreaticoduodenectomy for cancer: A meta-analysis
X. Z. Yu et al.
EJSO (2014)
A Meta-Analysis of Randomized Trials: Immediate Stent Placement vs. Surgical Bypass in the Palliative Management of Malignant Biliary Obstruction
Evan S. Glazer et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2014)
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)
Johanna A. M. G. Tol et al.
SURGERY (2014)
hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: A systematic review
Stina Nordh et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies
Agnieszka Anna Rucki et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Meta-analysis of the Efficacies of Extended and Standard Pancreatoduodenectomy for Ductal Adenocarcinoma of the Head of the Pancreas
Jingfeng Sun et al.
WORLD JOURNAL OF SURGERY (2014)
Early oral feeding after pancreatoduodenectomy enhances recovery without increasing morbidity
Arja Gerritsen et al.
HPB (2014)
Irinotecan Resistance is Accompanied by Upregulation of EGFR and Src Signaling in Human Cancer Models
Amelie Petitprez et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer
Michael A. Jacobetz et al.
GUT (2013)
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Trends in Racial Disparities in Pancreatic Cancer Surgery
Anand Shah et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
ERK1/2 activity contributes to gemcitabine resistance in pancreatic cancer cells
Chunning Zheng et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Malnutrition and pancreatic surgery: Prevalence and outcomes
Marco La Torre et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Paclitaxel-Induced Apoptosis Is BAK-Dependent, but BAX and BIM-Independent in Breast Tumor
Anna V. Miller et al.
PLOS ONE (2013)
Hypoxia counteracts taxol-induced apoptosis in MDA-MB-231 breast cancer cells: role of autophagy and JNK activation
A. Notte et al.
CELL DEATH & DISEASE (2013)
Clinical and molecular characterization of HER2 amplified-pancreatic cancer
Angela Chou et al.
GENOME MEDICINE (2013)
Preclinical Absorption, Distribution, Metabolism, and Excretion of an Oral Amide Prodrug of Gemcitabine Designed to Deliver Prolonged Systemic Exposure
Enaksha Wickremsinhe et al.
Pharmaceutics (2013)
The Impact of Vascular Resection on Early Postoperative Outcomes after Pancreaticoduodenectomy: An Analysis of the American College of Surgeons National Surgical Quality Improvement Program Database
Anthony W. Castleberry et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer
J. Harder et al.
BRITISH JOURNAL OF CANCER (2012)
Artery-first' approaches to pancreatoduodenectomy
P. Sanjay et al.
BRITISH JOURNAL OF SURGERY (2012)
Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations
Kristoffer Lassen et al.
CLINICAL NUTRITION (2012)
The miR-200 and miR-221/222 microRNA Families: Opposing Effects on Epithelial Identity
Erin N. Howe et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2012)
βII-Tubulin and βIII-Tubulin Mediate Sensitivity to Peloruside A and Laulimalide, but not Paclitaxel or Vinblastine, in Human Ovarian Carcinoma Cells
Arun Kanakkanthara et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Wan Zhang et al.
NATURE CELL BIOLOGY (2012)
Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer
Minyong Chen et al.
ONCOLOGY REPORTS (2012)
Pancreatectomy Combined with Superior Mesenteric Vein-Portal Vein Resection for Pancreatic Cancer: A Meta-analysis
Yanming Zhou et al.
WORLD JOURNAL OF SURGERY (2012)
Implementation of an enhanced recovery programme following pancreaticoduodenectomy
Nichola Robertson et al.
HPB (2012)
Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
G. M. A. Ajabnoor et al.
CELL DEATH & DISEASE (2012)
Arterial Resection During Pancreatectomy for Pancreatic Cancer A Systematic Review and Meta-Analysis
Nathan Mollberg et al.
ANNALS OF SURGERY (2011)
Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Pancreatic Cancer through MT1-MMP-Mediated Expression of HMGA2
Surabhi Dangi-Garimella et al.
CANCER RESEARCH (2011)
Tumor Engraftment in Nude Mice and Enrichment in Stroma-Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer
Ignacio Garrido-Laguna et al.
CLINICAL CANCER RESEARCH (2011)
Oxaliplatin: a review in the era of molecularly targeted therapy
T. Alcindor et al.
Current Oncology (2011)
Axitinib plus gemcitabine versus placebo plus gemcitabine in patients with advanced pancreatic adenocarcinoma: a double-blind randomised phase 3 study
Hedy L. Kindler et al.
LANCET ONCOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Ana-Maria Florea et al.
Cancers (2011)
Effect of Hospital Volume, Surgeon Experience, and Surgeon Volume on Patient Outcomes After Pancreaticoduodenectomy
C. Max Schmidt et al.
ARCHIVES OF SURGERY (2010)
Increased levels and defective glycosylation of MRPs in ovarian carcinoma cells resistant to oxaliplatin
Giovanni Luca Beretta et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)
H. Burger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Displacement of Bim by Bmf and Puma rather than increase in Bim level mediates paclitaxel-induced apoptosis in breast cancer cells
O. Kutuk et al.
CELL DEATH AND DIFFERENTIATION (2010)
Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial
Suzanne M. Jeurnink et al.
GASTROINTESTINAL ENDOSCOPY (2010)
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
Hedy Lee Kindler et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group-Directed Intergroup Trial S0205
Philip A. Philip et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Preoperative Biliary Drainage for Cancer of the Head of the Pancreas
Niels A. van der Gaag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model
Martine Humbert et al.
PLOS ONE (2010)
Total Pancreatectomy for Pancreatic Adenocarcinoma Evaluation of Morbidity and Long-Term Survival
Sushanth Reddy et al.
ANNALS OF SURGERY (2009)
Long-Term Survival After Multidisciplinary Management of Resected Pancreatic Adenocarcinoma
Matthew H. G. Katz et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Targeting AKT with the proapoptotic peptide, TAT-CTMP: A novel strategy for the treatment of human pancreatic adenocarcinoma
Peter O. Simon et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Peri-Operative Mortality and Long-Term Survival after Total Pancreatectomy for Pancreatic Adenocarcinoma: A Population-Based Perspective
Hari Nathan et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Variations in Referral Patterns to High-Volume Centers for Pancreatic Cancer
David C. Chang et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines
Eva Martinez-Balibrea et al.
MOLECULAR CANCER THERAPEUTICS (2009)
MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance
Taiki Moriyama et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
Xue Pan et al.
CLINICAL CANCER RESEARCH (2008)
Randomized crossover pharmacokinetic study of solvent-based paclitaxel and nab-paclitaxel
Erin R. Gardner et al.
CLINICAL CANCER RESEARCH (2008)
Significance of Organic Cation Transporter 3 (SLC22A3) Expression for the Cytotoxic Effect of Oxaliplatin in Colorectal Cancer
Sachiko Yokoo et al.
DRUG METABOLISM AND DISPOSITION (2008)
5-fluorouracil: Mechanisms of resistance and reversal strategies
Ning Zhang et al.
MOLECULES (2008)
National failure to operate on early stage pancreatic cancer
Karl Y. Bilimoria et al.
ANNALS OF SURGERY (2007)
Assessment of pancreatic malignancy with laparoscopy and intraoperative ultrasound
H. Doucas et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2007)
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer
Asma Sultana et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer:: A randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
Richard Herrmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Nuclear translocation of the tumor marker pyruvate kinase M2 induces programmed cell death
Attila Stetak et al.
CANCER RESEARCH (2007)
Disparities in the utilization of high-volume hospitals for complex surgery
Jerome H. Liu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Gemcitabine pharmacogenomics: cytidine deaminase and deoxycytidylate deaminase gene resequencing and functional genomics
JA Gilbert et al.
CLINICAL CANCER RESEARCH (2006)
Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of Cremophor-free, albumin-bound paclitaxel, ABI-007, compared with Cremophor-based paclitaxel
N Desai et al.
CLINICAL CANCER RESEARCH (2006)
Albumin-bound paclitaxel: a next-generation taxane
William J. Gradishar
EXPERT OPINION ON PHARMACOTHERAPY (2006)
CA 19-9 levels predict results of staging laparoscopy in pancreatic cancer
A Karachristos et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
Long-term survival is superior after resection for cancer in high-volume Centers
Y Fong et al.
ANNALS OF SURGERY (2005)
A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma
MB Farnell et al.
SURGERY (2005)
Molecular mechanisms of drug resistance
DB Longley et al.
JOURNAL OF PATHOLOGY (2005)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
JP Neoptolemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pancreaticoduodenectomy with vascular resection: Margin status and survival duration
JF Tseng et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2004)
FoxO3a transcriptional regulation of bim controls apoptosis in paclitaxel-treated breast cancer cell lines
A Sunters et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mechanisms of Taxol resistance related to microtubules
GA Orr et al.
ONCOGENE (2003)
Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death
A Arlt et al.
ONCOGENE (2003)
5-Fluorouracil: Mechanisms of action and clinical strategies
DB Longley et al.
NATURE REVIEWS CANCER (2003)
Decreased response to paclitaxel versus docetaxel in HER-2/neu transfected human breast cancer cells
LM Witters et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2003)
The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer - A prospective randomized multicenter trial with special focus on assessment of quality of life
NT Van Heek et al.
ANNALS OF SURGERY (2003)
Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity
Y Xu et al.
ANNALS OF ONCOLOGY (2002)
Cellular and molecular aspects of drugs of the future: oxaliplatin
AM Di Francesco et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Drug specific resistance to oxaliplatin is associated with apoptosis defect in a cellular model of colon carcinoma
I Gourdier et al.
FEBS LETTERS (2002)
Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2 - Randomized controlled trial evaluating survival, morbidity, and mortality
CJ Yeo et al.
ANNALS OF SURGERY (2002)
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
GJ Peters et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
The cellular pharmacology of oxaliplatin resistance
M Mishima et al.
EUROPEAN JOURNAL OF CANCER (2002)
Acquired resistance of pancreatic cancer cells towards 5-fluorouracil and gemcitabine is associated with altered expression of apoptosis-regulating genes
X Shi et al.
ONCOLOGY (2002)
ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy
Y Shirota et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Biliary stenting versus bypass surgery for the palliation of malignant distal bile duct obstruction: A meta-analysis
MC Taylor et al.
LIVER TRANSPLANTATION (2000)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer
S Giacchetti et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
